Patent Grant
11737713
The disclosure relates generally to medical device systems and, more particularly, medical device systems configured to monitor patient parameters.
Some types of medical devices may be used to monitor one or more physiological parameters of a patient. Such medical devices may include, or may be part of a system that includes, sensors that detect signals associated with such physiological parameters. Values determined based on such signals may be used to assist in detecting changes in patient conditions, in evaluating the efficacy of a therapy, or in generally evaluating patient health.
In general, the disclosure is directed to devices, systems, and techniques for monitoring a fall risk of a patient. The fall risk, in some cases, may indicate a likelihood that the patient will fall within a period of time following a reference time. As used herein, the term “fall” refers to an involuntary body position change induced by gravity, such as a fall from a standing position or a fall from a sitting position. A medical device system may determine a fall risk corresponding to a patient by monitoring one or more patient parameters over a period of time and analyzing a response of the one or more patient parameters to certain events. For example, the medical device system may determine how the one or more patient parameters change in response to a body position change (e.g., a sit-to-stand movement) or in response to a cardiac event (e.g., a premature ventricular contraction (PVC)) and determine the fall risk of the patient based on the determined change.
An implantable medical device (IMD) may include one or more electrodes configured to measure an electrogram (EGM) of the patient. The EGM may, in some cases, indicate a ventricular depolarization (e.g., an R-wave) of the patient's heart and a heart rate of the patient. Additionally, the IMD may determine tissue perfusion based on impedance sensed via the electrodes, and/or oxygen saturation using an optical sensor. Processing circuitry may determine a pulse transit time (PTT) associated with the patient based on the EGM, the impedance, the measured oxygen saturation, or any combination thereof. PTT is correlated with blood pressure. As such, processing circuitry may be configured to use a PTT measurement performed by the IMD as a representation of the blood pressure of the patient. In this way, the processing circuitry may be configured to track the blood pressure and the heart rate of the patient over a period of time.
Additionally, the IMD may include a 3-axis accelerometer which generates an accelerometer signal indicative of a posture of the patient, an activity level of the patient, a gait of the patient, and a body angle of the patient, as examples. This accelerometer signal may be used by the processing circuitry to perform a fall risk analysis. For example, the processing circuitry may be configured to identify one or more body position changes and determine how one or more patient parameters change in response to the each body position change of the one or more body position changes. For example, it may be expected that a heart rate and a blood pressure of the patient increases responsive to a sit-to-stand movement performed by the patient. Processing circuitry may determine that the patient is at an increased risk of falling if the blood pressure increase and the heart rate increase following a sit-to-stand movement of the patient are less than the expected increases. Additionally, or alternatively, the processing circuitry may determine that the patient is at an increased risk of falling in response to a change in a gait of the patient over time, a change in a stand-up speed of the patient over time, or any other determinable change in a patient parameter over time.
The techniques of this disclosure may provide one or more advantages. For example, it may be beneficial to create one or more “bins” for evaluating data collected by the IMD in order to determine a fall risk of the patient, such as a sit-to-stand bin, a lying-to-sit bin, and a lying-to-stand bin. Processing circuitry may analyze the heart rate and the blood pressure (and/or other parameters) following each sit-to-stand movement in the sit-to-stand bin, analyze the heart rate and the blood pressure following each lying-to-sit movement in the lying-to-sit bin, and analyze each lying-to-stand movement in the lying-to-stand bin. Based on analysis of each bin, e.g., based on a significant parameter value change over time in one or more of the bins, the processing circuitry may determine a fall risk of the patient. Segregating the data into different bins for different movements or events may facilitate a more meaningful comparison of the response of the patient to the events over time and more accurate identification of the risk of falling.
In some examples, a medical device system includes a medical device comprising a set of sensors configured to sense a set of signals, wherein the set of sensors comprises a motion sensor configured to generate a motion sensor signal which indicates a motion of a patient, wherein the set of signals includes the motion sensor signal. Additionally, a medical device system includes processing circuitry configured to identify, based on at least one signal of the set of signals, a time of an event corresponding to the patient, set a time window based on the time of the event, and save, to a fall risk database in a memory, a set of data including one or more signals of the set of signals so that the fall risk database may be analyzed in order to determine a fall risk score corresponding to the patient, wherein the set of data corresponds to the time window.
In some examples, a method includes sensing, by a medical device comprising a set of sensors, a set of signals, wherein the set of sensors comprises a motion sensor configured to generate a motion sensor signal which indicates a motion of a patient, wherein the set of signals includes the motion sensor signal, identifying, by the processing circuitry based on at least one signal of the set of signals, a time of an event corresponding to the patient and setting, by the processing circuitry, a time window based on the time of the event. Additionally, the method includes saving, by the processing circuitry to a fall risk database in a memory, a set of data including one or more signals of the set of signals so that the fall risk database may be analyzed in order to determine a fall risk score corresponding to the patient, wherein the set of data corresponds to the time window.
In some examples, a non-transitory computer-readable medium includes instructions for causing one or more processors to sense, by a medical device comprising a set of sensors, a set of signals, wherein the set of sensors comprises a motion sensor configured to generate a motion sensor signal which indicates a motion of a patient, wherein the set of signals includes the motion sensor signal and identify, based on at least one signal of the set of signals, a time of an event corresponding to the patient. Additionally, the instructions cause the one or more processors to set a time window based on the time of the event; and save, to a fall risk database in a memory, a set of data including one or more signals of the set of signals so that the fall risk database may be analyzed in order to determine a fall risk score corresponding to the patient, where the set of data corresponds to the time window.
The summary is intended to provide an overview of the subject matter described in this disclosure. It is not intended to provide an exclusive or exhaustive explanation of the systems, device, and methods described in detail within the accompanying drawings and description below. Further details of one or more examples of this disclosure are set forth in the accompanying drawings and in the description below. Other features, objects, and advantages will be apparent from the description and drawings, and from the claims.
This disclosure describes techniques for monitoring a fall risk of a patient. For example, an implantable medical device (IMD) may measure a set of patient parameters over a period of time. Processing circuitry may identify, based on one or more signals generated by the IMD, one or more events associated with the patient such as one or more body position changes and/or one or more cardiac events. The processing circuitry may analyze a manner in which at least one patient parameter of the set of patient parameters responds to each event of the one or more events. The processing circuitry may determine, based on the response of the patient parameters to the identified body position changes, the fall risk of the patient.
Falls may represent a significant challenge to some patients. As such, it may be beneficial to monitor one or more patient parameters, such as one or more patient parameters indicated by signals collected by medical device(s), in order to determine whether a patient is at risk of falling in the future. In some cases, falls are caused by arrhythmias such as any one or combination of asystole arrhythmias, tachycardia arrhythmias, bradycardia arrhythmias, or atrial fibrillation (AF). For example, a patient with bradycardia may have an abnormally low blood pressure or abnormally low heart rate. Consequently, a patient with bradycardia may experience lightheadedness when standing up, walking, or otherwise exerting effort. This lightheadedness may cause the patient to fall, in some cases. Other diseases or conditions such as Heart Failure, chronic obstructive pulmonary disease (COPD), seizures, and dementia (e.g., Parkinson's Disease, Multiple Sclerosis, and Alzheimer's Disease), may also lead to falls. In addition, older patients may be at an increased risk of falling.
In any case, it may be beneficial to analyze signals recorded by one or more medical devices in order to track a patient's risk of falling. If a patient is determined to be at an increased risk of falling, processing circuitry may output an alert, output a recommendation for treatment, and/or cause one or more medical devices to deliver treatment to the patient. In some examples, the processing circuitry monitor and bin one or more parameters including blood pressure, heart rate, tissue perfusion, motion data, and gyroscopic data. The processing circuitry may analyze the one or more parameters in order to determine the patient's risk of falling.
In some examples, IMD 10 is implanted outside of a thoracic cavity of patient 4 (e.g., subcutaneously in the pectoral location illustrated in
Clinicians sometimes diagnose patients with medical conditions based on one or more observed physiological signals collected by physiological sensors, such as electrodes, optical sensors, chemical sensors, temperature sensors, acoustic sensors, and motion sensors. In some cases, clinicians apply non-invasive sensors to patients in order to sense one or more physiological signals while a patient is in a clinic for a medical appointment. However, in some examples, physiological markers (e.g., irregular heartbeats and long-term respiration trends) of a patient condition are rare or are difficult to observe over a relatively short period of time. As such, in these examples, a clinician may be unable to observe the physiological markers needed to diagnose a patient with a medical condition while monitoring one or more physiological signals of the patient during a medical appointment. Additionally, it may be beneficial to monitor one or more patient parameters for an extended period of time (e.g., days, weeks, or months) so that the one or more parameters may be analyzed to identify one or more changes or trends over the extended period of time. In the example illustrated in
In some examples, IMD 10 includes one or more sensor(s) which are configured to detect physiological signals of patient 4. For example, IMD 10 includes a set of electrodes (not illustrated in
Moreover, IMD 10 may additionally or alternatively include one or more optical sensors, motion sensors (e.g., accelerometers), temperature sensors, chemical sensors, pressure sensors, or any combination thereof. Such sensors may detect one or more physiological parameters indicative of a patient condition.
For example, IMD 10 includes one or more accelerometers. An accelerometer of IMD 10 may collect an accelerometer signal which reflects a measurement of a motion of patient 4. In some cases, the accelerometer may collect a three-axis accelerometer signal indicative of patient 4's movements within a three-dimensional Cartesian space. For example, the accelerometer signal may include a vertical axis accelerometer signal vector, a lateral axis accelerometer signal vector, and a frontal axis accelerometer signal vector. The vertical axis accelerometer signal vector may represent an acceleration of patient 4 along a vertical axis, the lateral axis accelerometer signal vector may represent an acceleration of patient 4 along a lateral axis, and the frontal axis accelerometer signal vector may represent an acceleration of patient 4 along a frontal axis. In some cases, the vertical axis substantially extends along a torso of patient 4 from a neck of patient 4 to a waist of patient 4, the lateral axis extends across a chest of patient 4 perpendicular to the vertical axis, and the frontal axis extends outward from and through the chest of patient 4, the frontal axis being perpendicular to the vertical axis and the lateral axis.
IMD 10 may include an optical sensor. The optical sensor may, in some cases, include two or more light emitters and one or more light detectors. The optical sensor may perform one or more measurements in order to determine an oxygenation of the tissue of Patient 4. For example, the optical sensor may perform one or more tissue oxygen saturation (StO2) measurements. StO2 may, in some examples, represent a weighted average between Arterial blood oxygen saturation (SaO2) and venous oxygen saturation (SvO2). In some examples, the optical sensor may perform one or more pulse oximetry (SpO2) measurements. SpO2 may, in some cases, represent an approximation of SaO2. Oxygen saturation (e.g., StO2, SaO2, SvO2, and SpO2) trends may be indicative of one or more patient conditions, such as heart failure, sleep apnea, or COPD, as examples. For example, a steady decline of StO2 values over a period time may indicate a worsening risk of a heart failure exacerbation in a patient. As such, the IMD may perform several StO2 measurements over a period of time (e.g., hours, days, weeks, or months) and the processing circuitry may identify a trend of StO2 values using data from the StO2 measurements. Based on the identified trend, the processing circuitry may, in some cases, identify a medical condition present in the patient or monitor a condition that is already known to be present in the patient.
During the respective StO2 measurement, the light emitters of the optical sensor may output light to an area of tissue proximate to the IMD, the light including a first set of frequency components. The one or more light detectors may sense light including a second set of frequency components. The processing circuitry is configured to compare the first set of frequency components and the second set of frequency components to identify an StO2 value corresponding to the respective StO2 measurement, where the StO2 value represents a ratio of oxygen-saturated hemoglobin located in the area of tissue to a total amount of hemoglobin located in the area of tissue.
External device 12 may be a computing device configured for use in settings such as a home, clinic, or hospital, and may further be configured to communicate with IMD 10 via wireless telemetry. For example, external device 12 may be coupled to a remote patient monitoring system, such as Carelink®, available from Medtronic plc, of Dublin, Ireland. External device 12 may, in some examples, include a programmer, an external monitor, or a consumer device such as a smart phone or tablet.
In other examples, external device 12 may be a larger workstation or a separate application within another multi-function device, rather than a dedicated computing device. For example, the multi-function device may be a notebook computer, tablet computer, workstation, one or more servers, cellular phone, personal digital assistant, or another computing device that may run an application that enables the computing device to operate as a secure device.
When external device 12 is configured for use by the clinician, external device 12 may be used to transmit instructions to IMB 10. Example instructions may include requests to set electrode combinations for sensing and any other information that may be useful for programming into IMD 10. The clinician may also configure and store operational parameters for IMD 10 within IMD 10 with the aid of external device 12. In some examples, external device 12 assists the clinician in the configuration of IMD 10 by providing a system for identifying potentially beneficial operational parameter values.
Whether external device 12 is configured for clinician or patient use, external device 12 is configured to communicate with IMB 10 and, optionally, another computing device (not illustrated in
Processing circuitry 14, in some examples, may include one or more processors that are configured to implement functionality and/or process instructions for execution within IMB 10, external device 12, one or more other devices, or any combination thereof. For example, processing circuitry 14 may be capable of processing instructions stored in a memory. Processing circuitry 14 may include, for example, microprocessors, digital signal processors (DSPs), application specific integrated circuits (ASICs), field-programmable gate arrays (FPGAs), or equivalent discrete or integrated logic circuitry, or a combination of any of the foregoing devices or circuitry. Accordingly, processing circuitry 14 may include any suitable structure, whether in hardware, software, firmware, or any combination thereof, to perform the functions ascribed herein to processing circuitry 14.
Processing circuitry 14 may represent processing circuitry located within any combination of IMD 10 and external device 12. In some examples, processing circuitry 14 may be entirely located within a housing of IMD 10. In other examples, processing circuitry 14 may be entirely located within a housing of external device 12. In other examples, processing circuitry 14 may be located within any combination of IMD 10, external device 12, and another device or group of devices that are not illustrated in
A memory (not illustrated in
The memory may represent a memory located within any one or both of IMB 10 and external device 12. In some examples, the memory may be entirely located within a housing of IMD 10. In other examples, the memory may be entirely located within a housing of external device 12. In other examples, the memory may be located within any combination of IMD 10, external device 12, and another device or group of devices that are not illustrated in
Medical device system 2 of
Processing circuitry 14 may identify, based on the accelerometer signal collected by the accelerometer of IMD 10, one or more body position changes of patient 4. Examples of body position changes which processing circuitry 14 may identify in the accelerometer signal include sit-to-stand movements, lying-to-sit movements, lying-to-stand movements, stand-to-sit movements, stand-to-lying movements, sit-to-lying movements, among other body position changes. For example, processing circuitry 14 may identify a change in a magnitude of one or more axes of the accelerometer signal and identify one or more body position changes based on the change.
In some examples, processing circuitry 14 may identify a body angle of patient 4. As used herein, the term “body angle” may refer to an angle of a torso of patient 4. For example, IMD 10 may be implanted in a torso of patient 4. As such, the accelerometer signal generated by IMD 10 reflects the body angle of the torso of the patient. A zero degree body angle, in some cases, may represent a body angle where the torso is parallel to the ground (e.g., when patient 4 is lying down. A ninety degree body angle, in some cases, may represent a body angle where the torso is perpendicular to the ground (e.g., when patient 4 is standing up or when patient 4 is sitting in an upright position). As such, processing circuitry 14 may be able to identify when patient 4 leans forward while standing or bends the torso forward while sitting by identifying a change in the body angle which is indicated by the accelerometer signal.
Processing circuitry 14 may be configured to determine a gait of patient 4 based on the accelerometer signal collected by IMD 10 while patient 4 is walking or running. For example, processing circuitry 14 may be configured to determine a step rate in which patient 4 is stepping. Additionally, or alternatively, processing circuitry 14 may be configured to calculate, based on the accelerometer signal, a stability score corresponding to the gait of patient 4.
Consequently, IMD 10 may be configured to measure a set of physiological parameters and generate an accelerometer signal which indicates one or more aspects of a physical position and movements of patient 4. Processing circuitry 14 may be configured to analyze data collected by IMD 10 in order to determine one or more statuses and risk factors of patient 4, such as a risk that patient 4 will fall within a period of time after a current time. For example, processing circuitry 14 may maintain a fall risk database which stores a plurality of sets of data each corresponding to a respective body position movement or body angle change. Processing circuitry 14 may update the fall risk database on a rolling basis. For example, processing circuitry 14 may add a set of data to the plurality of sets of data stored in the fall risk database when processing circuitry 14 detects a body position movement or body angle change. In some cases, processing circuitry 14 may remove one or more sets of data from the fall risk database.
Processing circuitry 14 may analyze the plurality of sets of data currently stored by fall risk database in order to determine a fall risk score associated with patient 4. In some examples, processing circuitry 14 may analyze the plurality of sets of data currently stored by the fall risk database on a regular basis (e.g., hourly, daily, weekly, or any other time interval). Additionally, or alternatively, processing circuitry 14 may analyze the plurality of sets of data currently stored by the fall risk database in response to receiving an instruction (e.g., from external device 12 or another user device) to analyze the data. In any case, when processing circuitry 14 determines a fall risk score associated by patient 4, processing circuitry 14 may determine the fall risk score based on one or more sets of data currently stored in the fall risk database. In some examples, the fall risk score may be referred to as a “fall risk index.”
Each set of data stored by the fall risk database may include one or more portions of signals measured by IMD 10, other implantable devices, other external devices, or any combination thereof. For example, IMD 10 may collect one or more of the accelerometer signal, an EGM, one or more tissue oxygenation signals (StO2 and/or SpO2), and one or more other signals. When IMD 10 collects a signal, IMD 10 may collect a sequence of samples corresponding to the respective signal, and the sequence of samples may represent the signal itself. Consequently, a “portion” of the signal may represent set of consecutive samples of the signal. Each set of data stored by the fall risk database may include a portion of each signal of a set of signals, where each respective portion corresponds to a respective window of time. In some examples, the window of time corresponds to a time in which processing circuitry 14 detects a body position change or a body angle change in the accelerometer signal.
Processing circuitry 14 may be configured to identify, based on the accelerometer signal collected by IMD 10, a body position change of patient. Additionally, processing circuitry 14 may be configured to identify a time or a period of time in which the body position change occurs. Processing circuitry 14 may identify a type of the body position movement. For example, processing circuitry 14 may determine that the body position movement represents a sit-to-stand movement, a lying-to-sit movement, a lying-to-stand movement, a stand-to-sit movement, a stand-to-lying movement, a sit-to-lying movement, or another type of movement. Additionally, or alternatively, processing circuitry 14 may identify the type of the body position movement based on a body angle change associated with the body position movement. In one example, processing circuitry 14 may determine that the body position movement represents a change from a 40 degree body angle to a 90 degree body angle.
Processing circuitry 14 may set a time window based on the time or the period of time in which a body position change occurs. For example, processing circuitry 14 may set the time window to begin at a first time and end at a second time, with the first and second times being identified relative to the time or period of time in which the body position change occurs. In some examples, the first time represents a time in which the respective body position change begins. In some examples, the first time represents a time in which the respective body position change ends. In some examples, the first time represents a time between the time in which the body position change begins and the time in which the body position change ends. In some examples, the first time is a predetermined amount of time before the time or period of time in which the respective body position change occurs. In some examples, the first time is a predetermined amount of time after the time or period of time in which the respective body position change occurs. In some examples, the second time is a predetermined amount of time after the time or period of time in which the respective body position change occurs, where the second time is after the first time. In any case, the time window may include at least a portion of time following the respective body position movement.
In some cases, processing circuitry 14 may save, to the fall risk database stored in a memory (not illustrated in
The fall risk database may include a plurality of sets of data each corresponding to a respective body position movement and the fall risk database may include a plurality of “bins” configured to store one or more sets of data of the plurality of sets of data. For example, each bin of the plurality of bins may be associated with a respective classification of a plurality of classifications. When processing circuitry 14 identifies a body position change, processing circuitry 14 may assign one or more classifications to the identified body position change. In some examples, the plurality of classifications may include a sit-to-stand classification, a lying-to-sit classification, a lying-to-stand classification, a stand-to-sit classification, a stand-to-lying classification, and a sit-to-lying classification. In some examples, the plurality of classifications may include one or more body angle change classifications, where each body angle change classification of the one or more body angle change classifications is associated with a first range of body angles and a second range of body angles. A body angle change representing a change from a first body angle to a second body angle may fit within a body angle change classification if the first body angle falls within the first range of body angles associated with the classification and if the second body angle falls within the second range of body angles associated with the classification. In some examples, the plurality of classifications may include one or more other types of classifications such as time of day classifications.
In one example, when processing circuitry 14 detects a lying-to-stand movement which represents a body angle change from zero degrees to ninety degrees, processing circuitry 14 may assign the lying-to-stand classification and a respective body angle change classification to the detected lying-to-stand movement. When processing circuitry 14 generates a set of data corresponding to the lying-to-stand movement, processing circuitry 14 may save the set of data to each bin of the plurality of bins which is associated with a classification assigned to the lying-to-stand movement.
For each set of data generated responsive to detecting a body position change, processing circuitry 14 may save the set of data to each bin of the plurality of bins which is associated with a classification assigned to the detected body position change. This allows processing circuitry 14 to select one or more bins of the plurality of bins for a fall risk analysis. That is, processing circuitry 14 may determine a fall risk score based on one or more bins of the plurality of bins. In some examples, processing circuitry 14 may calculate a fall risk sub-score for each bin of the one or more bins and calculate a fall risk score based on each respective fall risk sub-score. In other words, processing circuitry 14 may determine a fall risk evidence level for each metric of a plurality of metrics. The “metrics” may correspond to the bins of the fall risk database. An “evidence level” may refer to an amount of evidence that patient 4 is at risk of falling. Processing circuitry 14 may determine an overall fall risk score for patient 4 based on the fall risk evidence level corresponding to each metric of the plurality of metrics.
Processing circuitry 14 may be configured to identify one or more patient parameters based on physiological signals measured by IMD 10 or other devices. In some examples, processing circuitry 14 may be configured to determine a heart rate of patient 4 based on the EGM signal measured via one or more electrodes of IMD 10. In some examples, processing circuitry 14 may determine a blood pressure of patient 4 or one or more values corresponding to the blood pressure of patient 4 based on an EGM, an impedance signal, a tissue perfusion signal (e.g., collected by an optical sensor), or any combination thereof. Additionally, or alternatively, processing circuitry 14 may determine a speed of one or more body position movements detected in the accelerometer signals, identify a stability of a gait identified in the accelerometer signal, determine one or more tissue perfusion values identified in the optical signal sensed by IMD 10 via the optical sensor, determine one or more other patient parameters based on signals collected by IMD 10 or other devices, or any combination thereof.
In some examples, to determine the heart rate of patient 4, processing circuitry 14 may determine the heart rate based on two or more R-waves detected in the EGM collected by IMD 10. For example, the EGM may include one or more R-waves each representing a ventricular depolarization of the heart of Patient 4. The rate of R-waves in the EGM may represent the heart rate of patient 4. As such, processing circuitry 14 may determine the heart rate of patient 4 over a period of time by determining the rate of R-waves in the EGM over the period of time. In some examples, the processing circuitry 14 may determine an amount of time between a first R-wave and a second R-wave consecutive to the first-wave. Based on the amount of time between the first R-wave and the second R-wave, the processing circuitry 14 may determine a heart rate of the patient 4 at the time of the second R-wave. Processing circuitry 14 may calculate the respective heart rate corresponding to each pair of consecutive R-waves in the EGM. As such, processing circuitry 14 may monitor the heart rate of patient 4 over time.
It may be expected that the blood pressure and/or the heart rate of patient 4 will increase in response to a body position movement such as a sit-to-stand movement. If the blood pressure and/or the heart rate of patient 4 do not increase by at least an expected amount in response to a body position movement, the patient 4 may experience light-headedness soon after completing the sit-to-stand movement. Such light-headedness may, in some examples, lead to patient 4 losing consciousness and/or falling. As such, it may be beneficial for processing circuitry 14 to analyze respective sets of data corresponding to each sit-to-stand movement detected in the accelerometer signal. That is, processing circuitry 14 may analyze the sit-to-stand bin in the fall risk database in order to determine a fall risk score for the patient 4. When processing circuitry 14 determines that increases in heart rate and increases in blood pressure responsive to respective sit-to-stand movements are decreasing over a period of time or have decreased below a threshold expected increase, processing circuitry 14 may determine that the patient is at risk of falling in the future. In addition to or alternatively to blood pressure and heart rate, processing circuitry 14 may analyze one or more other patient parameters indicated by respective bins of data within the fall risk database in order to determine a fall risk score of patient 4.
Although one or more techniques described herein include generating sets of data for fall risk analysis based on detecting a body position change and/or detecting a body angle change, processing circuitry 14 may also generate sets of data for fall risk analysis based on one or more other events. For example, processing circuitry 14 may generate a set of data responsive to detecting a heart event such as a pre-ventricular contraction (PVC) and save the set of data to the fall risk database. In some examples, processing circuitry 14 may assign one or more classifications to the set of data generated responsive to detecting the heart event and save the set of data to one or more bins of the fall risk database corresponding to the assigned classifications. In turn, processing circuitry 14 may analyze one or more of the bins in order to determine a fall risk score for patient 4.
As discussed above, processing circuitry 14 may monitor the accelerometer signal for one or more body position movements of patient 4 (e.g., sit-to-stand movements, lying-to-sit movements, lying-to-stand movements, standing-to-sit movements, standing-to-lying movements, and sit-to-lying movements). Additionally, or alternatively, processing circuitry 14 may monitor the accelerometer signal in order to determine a walking distance covered by patient 4. In some examples, processing circuitry 14 may determine the walking distance covered by patient 4 following each detected body position movement and store this information in a memory.
Processing circuitry 14, may determine, based on the accelerometer signal measured by IMD 10, an amount of time it takes for patient 4 to complete each body position movement detected by processing circuitry 14. For example, in the case of a sit-to-stand movement, processing circuitry 14 may determine, based on the accelerometer signal, a first time in which patient 4 begins standing up and a second time in which patient 4 finishes standing up. The difference between the first time and the second time represents the time it takes patient 4 to complete the sit-to-stand movement. Processing circuitry 14 may save the amount of time it takes to complete each detected body position movement in the fall risk database. Subsequently, processing circuitry 14 may analyze the amount of time it takes for patient 4 to complete one or more body position changes over a period of time. For example, processing circuitry 14 may analyze several sit-to-stand movements over the course of a week and determine that it is taking progressively longer for patient 4 to complete these sit-to-stand movements. In this example, processing circuitry 14 may determine that patient 4 is at an increased risk of falling. In some examples, patient 4 may perform a five times sit-to-stand (FTSTS) test, and processing circuitry 14 may save an amount of time it takes patient 4 to complete each sit-to-stand movement of the FTSTS movement.
The accelerometer signal collected by IMD 10 may indicate one or more body angle changes (e.g., one or more trunk angular displacements (TADs)). Additionally, or alternatively, the accelerometer single may indicate a gait speed (e.g., 4-meter gait speed (4MGS)) of patient 4 while patient 4 is walking or running and the accelerometer signal may indicate a gait stability of patient 4. Processing circuitry 14 may determine gait stability by tracking a variability of the accelerometer signal over a period of time. A greater variability in the accelerometer signal may represent a greater instability of the gait of patient 4 and indicate a greater risk of patient 4 falling.
Processing circuitry 14 may measure, for each time that patient 4 stands up, an amount of time that it takes for patient 4 to begin moving (e.g., begin walking) after patient 4 finishes standing up. This time between standing up and moving may be referred to herein as an expanded Timed Get-Up-and-Go (ETGUG). If the amount of time that it takes patient 4 to begin moving after standing up increases throughout a sequence of sit-to-stand movements detected in the accelerometer signal, processing circuitry 14 may determine that a risk of patient 4 falling is increasing as compared with examples in which the amount of time that it takes patient 4 to begin moving after standing up remains the same or decreases throughout a sequence of sit-to-stand movements. For example, when patient 4 pauses after standing up, this may indicate that patient 4 is experiencing lightheadedness after standing up, which increases the risk of falling as compared to when patient 4 does not experience lightheadedness after standing up.
Respective to detecting a body position movement in the accelerometer signal, processing circuitry 14 is configured to monitor blood pressure (e.g., PTT), heart rate, tissue perfusion changes, or any combination thereof over a window of time corresponding to the detecting the body position movement (e.g., a window of time extending within a range from 5 to 60 seconds following the body position movement. Specifically, processing circuitry 14 may monitor a heart rate recovery following an orthostatic challenge and monitor a blood pressure recovery following an orthostatic challenge.
In some examples, processing circuitry 14 may calculate a plurality of PTT intervals in order to track the blood pressure of patient 4 over a period of time. For example, processing circuitry 14 is configured to identify, for a set of data stored in the fall risk database, a plurality of PTT intervals. In some examples, each PTT interval of the plurality of PTT intervals represents an amount of time between a depolarization indicated by a respective portion of the EGM and an impedance feature indicated by a respective portion of the impedance signal that occurs after the respective depolarization and before a subsequent depolarization indicated by the respective portion of the EGM. In some examples, each PTT interval of the plurality of PTT intervals represents an amount of time between a depolarization indicated by a respective portion of the EGM and a tissue oxygenation feature indicated by a respective portion of a tissue oxygenation signal (e.g., StO2 and/or SpO2) that occurs after the respective depolarization and before a subsequent depolarization indicated by the respective portion of the EGM.
In any case, PTT may represent a parameter which indicates an amount of time which it takes blood to flow from the heart to a peripheral location within the cardiovascular system. For example, the EGM indicates a time in which the ventricles of patient 4 contract, forcing blood out of the heart. The impedance signal measured by IMD 10 indicates a tissue perfusion of tissue proximate to IMD 10. Tissue perfusion increases as blood flows to the tissue proximate to IMD 10 (e.g., during a pulse which is caused by blood flowing out of the heart of patient 4). Moreover, tissue oxygenation (e.g., StO2 and/or SpO2) increases as blood flows to the tissue proximate to IMD 10 (e.g., during a pulse). Consequently, an amount of time between an R-wave detected in the EGM and an impedance signal feature detected in the impedance signal collected by IMD 10 may represent a PTT interval. Additionally, or alternatively, an amount of time between an R-wave detected in the EGM and a tissue oxygenation feature detected in the tissue oxygenation signal may represent a PTT interval. PTT intervals may have an inverse relationship with blood pressure. For example, a shorter PTT interval represents a greater flow speed of blood, which indicates a higher blood pressure. Alternatively, a longer PTT interval represents a lower flow speed of blood, which indicates a lower blood pressure. In any case, a relationship may exist between blood pressure and PTT intervals of patient 4. As such, PTT interval values be used by processing circuitry 14 as a stand-in or a proxy for blood pressure values.
Processing circuitry 14 may determine, based on a plurality of PTT intervals corresponding to a respective set of data, a PTT change value corresponding to a time window associated with the set of data. The PTT change value represents a change between one or more PTT intervals in a first section of the respective time window and one or more PTT intervals in a second section of the time window. Processing circuitry 14 may calculate, based on the PTT change value corresponding one or more sets of data stored in the fall risk database, a fall risk score corresponding to patient 4.
Although in one example IMD 10 takes the form of an ICM, in other examples, IMD 10 takes the form of any combination of implantable cardioverter defibrillators (ICDs) with intravascular or extravascular leads, pacemakers, cardiac resynchronization therapy devices (CRT-Ds), neuromodulation devices, left ventricular assist devices (LVADs), implantable sensors, orthopedic devices, or drug pumps, as examples. Moreover, although described in the context of an IMD, the techniques of this disclosure may be implemented by systems that additionally or alternatively include one or more external sensor devices, such as a wearable patient monitor, smartwatch, or Fitbit.
In the example shown in
In some examples, a spacing between proximal electrode 16A and distal electrode 16B may range from about 30-55 mm, about 35-55 mm, or about 40-55 mm, or more generally from about 25-60 mm. Overall, IMD 10 may have a length L of about 20-30 mm, about 40-60 mm, or about 45-60 mm. In some examples, the width W of major surface 18 may range from about 3-10 mm, and may be any single width or range of widths between about 3-10 mm. In some examples, a depth D of IMD 10 may range from about 2-9 mm. In other examples, the depth D of IMD 10 may range from about 2-5 mm, and may be any single or range of depths from about 2-9 mm. In any such examples, IMD 10 is sufficiently compact to be implanted within the subcutaneous space of patient 4 in the region of a pectoral muscle.
IMD 10, according to an example of the present disclosure, may have a geometry and size designed for ease of implant and patient comfort. Examples of IMD 10 described in this disclosure may have a volume of 3 cubic centimeters (cm3) or less, 1.5 cm3 or less, or any volume therebetween. In addition, in the example shown in
In the example shown in
Proximal electrode 16A and distal electrode 16B may be used to sense cardiac EGMs (e.g., cardiac ECGs) when IMD 10 is implanted subcutaneously in patient 4. In some examples, processing circuitry of IMD 10 also may determine whether cardiac EGMs of patient 4 are indicative of arrhythmia or other abnormalities, which processing circuitry of IMD 10 may evaluate in determining whether a medical condition (e.g., heart failure, sleep apnea, or COPD) of patient 4 has changed. The cardiac EGMs may be stored in a memory of the IMD 10. In some examples, data derived from the EGMs may be transmitted via integrated antenna 26 to another medical device, such as external device 12. In some examples, one or both of electrodes 16A and 16B also may be used by IMD 10 to collect one or more impedance signals (e.g., a subcutaneous tissue impedance) during impedance measurements performed by IMD 10. In some examples, such impedance values detected by IMD 10 may reflect a resistance value associated with a contact between electrodes 16A, 16B, and target tissue of patient 4. Additionally, in some examples, electrodes 16A, 16B may be used by communication circuitry of IMD 10 for tissue conductance communication (TCC) communication with external device 12 or another device.
In the example shown in
In the example shown in
IMD 10 may include several features for retaining IMD 10 in position once subcutaneously implanted in patient 4. For example, as shown in
Electrodes 16A and 16B may be used to sense cardiac EGMs, as described above. Additional electrodes 16C and 16D may be used to sense subcutaneous tissue impedance, in addition to or instead of electrodes 16A, 16B, in some examples. In some examples, processing circuitry of IMD 10 may determine an impedance value of patient 4 based on signals received from at least two of electrodes 16A-16D. For example, processing circuitry of IMD 10 may generate one of a current or voltage signal, deliver the signal via a selected two or more of electrodes 16A-16D, and measure the resulting other of current or voltage. Processing circuitry of IMD 10 may determine an impedance value based on the delivered current or voltage and the measured voltage or current.
In the example shown in
In some examples, techniques for determining StO2 may include using light emitter(s) 38 to emit light at one or more VIS wavelengths (e.g., approximately 660 nm) and at one or more NIR wavelengths (e.g., approximately 850-890 nm). The combination of VIS and NIR wavelengths may help enable processing circuitry of IMD 10 to distinguish oxygenated hemoglobin from deoxygenated hemoglobin in the tissue of patient 4, since as hemoglobin becomes less oxygenated, an attenuation of VIS light increases and an attenuation of NIR decreases. By comparing the amount of VIS light detected by light detectors 40A, 40B to the amount of NIR light detected by light detectors 40A, 40B, processing circuitry of IMD 10 may determine the relative amounts of oxygenated and deoxygenated hemoglobin in the tissue of patient 4. For example, if the amount of oxygenated hemoglobin in the tissue of patient 4 decreases, the amount of VIS light detected by light detectors 40A, 40B increases and the amount of NIR light detected by light detectors 40A, 40B decreases. Similarly, if the amount of oxygenated hemoglobin in the tissue of patient 4 increases, the amount of VIS light detected by light detectors 40A, 40B decreases and the amount of NIR light detected by light detectors 40A, 40B increases.
As shown in
Light emitter(s) 38 may emit light into a target site of patient 4 during a technique for determining an StO2 value of patient 4. The target site may generally include the interstitial space around IMD 10 when IMD 10 is implanted in patient 4. Light emitter(s) 38 may emit light directionally in that light emitter(s) 38 may direct the signal to a side of IMD 10, such as when light emitter(s) 38 are disposed on the side of IMD 10 that includes first major surface 18. The target site may include the subcutaneous tissue adjacent IMD 10 within patient 4.
Techniques for determining an StO2 value may be based on the optical properties of blood-perfused tissue that change depending upon the relative amounts of oxygenated and deoxygenated hemoglobin in the microcirculation of tissue. These optical properties are due, at least in part, to the different optical absorption spectra of oxygenated and deoxygenated hemoglobin. Thus, the oxygen saturation level of the patient's tissue may affect the amount of light that is absorbed by blood within the tissue adjacent IMD 10, and the amount of light that is reflected by the tissue. Light detectors 40A, 40B each may receive light from light emitter(s) 38 that is reflected by the tissue, and generate electrical signals indicating the intensities of the light detected by light detectors 40A, 40B. Processing circuitry of IMD 10 then may evaluate the electrical signals from light detectors 40A, 40B in order to determine an StO2 value of patient 4.
In some examples, a difference between the electrical signals generated by light detectors 40A, 40B may enhance an accuracy of the StO2 value determined by IMD 10. For example, because tissue absorbs some of the light emitted by light emitter(s) 38, the intensity of the light reflected by tissue becomes attenuated as the distance (and amount of tissue) between light emitter(s) 38 and light detectors 40A, 40B increases. Thus, because light detector 40B is positioned further from light emitter(s) 38 (at distance S+N) than light detector 40A (at distance S), the intensity of light detected by light detector 40B should be less than the intensity of light detected by light detector 40A. Due to the close proximity of detectors 40A, 40B to one another, the difference between the intensity of light detected by light detector 40A and the intensity of light detected by light detector 40B should be attributable only to the difference in distance from light emitter(s) 38. In some examples, processing circuitry of IMD 10 may use the difference between the electrical signals generated by light detectors 40A, 40B, in addition to the electrical signals themselves, in determining an StO2 value of patient 4.
In some examples, IMD 10 may include one or more additional sensors, such as one or more accelerometers (not illustrated in
In some examples, IMD 10 may perform an SpO2 measurement using light emitter(s) 38 and light detectors 40. For example, IMD 10 may perform SpO2 measurements by using light emitter(s) 38 to emit light at one or more VIS wavelengths, one more NIR wavelengths, or a combination of one or more VIS wavelengths and one more NIR wavelengths. By comparing the amount of VIS light detected by light detectors 40A, 40B to the amount of NIR light detected by light detectors 40A, 40B, processing circuitry of IMD 10 may determine the relative amounts of oxygenated and deoxygenated hemoglobin in the tissue of patient 4. For example, if the amount of oxygenated hemoglobin in the tissue of patient 4 decreases, the amount of VIS light detected by light detectors 40A, 40B increases and the amount of NIR light detected by light detectors 40A, 40B decreases. Similarly, if the amount of oxygenated hemoglobin in the tissue of patient 4 increases, the amount of VIS light detected by light detectors 40A, 40B decreases and the amount of NIR light detected by light detectors 40A, 40B increases.
Although SpO2 measurements and StO2 measurements may both employ the optical sensor (e.g., light emitter(s) 38 and light detectors 40) of IMD 10 to emit and sense light, SpO2 measurements may consume significantly more energy than StO2 measurements. In some examples, an SpO2 measurement may consume up to 3 orders of magnitude (1,000 times) more power than an StO2 measurement. Reasons for the energy consumption disparity include that SpO2 measurements may require light emitter(s) 38 to be activated for up to 30 seconds, where StO2 measurements may require light emitter(s) 38 to be activated for up to 5 seconds. Additionally, SpO2 measurements may require a sampling rate of up to 70 Hz, whereas StO2 measurements may require a sampling rate of up to 4 Hz.
Processing circuitry 50 may include fixed function circuitry and/or programmable processing circuitry. Processing circuitry 50 may include, for example, microprocessors, DSPs, ASICs, FPGAs, equivalent discrete or integrated logic circuitry, or a combination of any of the foregoing devices or circuitry. Accordingly, processing circuitry 50 may include any suitable structure, whether in hardware, software, firmware, or any combination thereof, to perform the functions ascribed herein to IMD 10. In some examples, processing circuitry 50 may represent at least a portion of processing circuitry 14 of
Sensing circuitry 52 and communication circuitry 54 may be selectively coupled to electrodes 16 via switching circuitry 58, which may be controlled by processing circuitry 50. Sensing circuitry 52 may monitor signals from electrodes 16 in order to monitor electrical activity of heart (e.g., to produce an EGM), and/or subcutaneous tissue impedance, the impedance being indicative of at least some aspects of patient 4's cardiac activity and/or respiratory patterns. Sensing circuitry 52 also may monitor signals from sensors 62, which may include light detectors 40, motion sensor(s) 42, and any additional sensors that may be positioned on IMD 10. In some examples, sensing circuitry 52 may include one or more filters and amplifiers for filtering and amplifying signals received from one or more of electrodes 16 and/or sensor(s) 62.
Communication circuitry 54 may include any suitable hardware, firmware, software or any combination thereof for communicating with another device, such as external device 12 or another device or sensor, such as a pressure sensing device. Under the control of processing circuitry 50, communication circuitry 54 may receive downlink telemetry from, as well as send uplink telemetry to, external device 12 or another device with the aid of an internal or external antenna, e.g., antenna 26. In addition, processing circuitry 50 may communicate with a networked computing device via an external device (e.g., external device 12) and a computer network, such as the Medtronic CareLink® Network developed by Medtronic, plc, of Dublin, Ireland.
A clinician or other user may retrieve data from IMD 10 using external device 12, or by using another local or networked computing device configured to communicate with processing circuitry 50 via communication circuitry 54. The clinician may also program parameters of IMD 10 using external device 12 or another local or networked computing device.
In some examples, memory 56 includes computer-readable instructions that, when executed by processing circuitry 50, cause IMD 10 and processing circuitry 50 to perform various functions attributed to IMD 10 and processing circuitry 50 herein. Memory 56 may include one or both of a short-term memory or a long-term memory. The memory may include, for example, RAM, DRAM, SRAM, magnetic discs, optical discs, flash memories, or forms of EPROM or EEPROM. In some examples, the memory is used to store program instructions for execution by processing circuitry 50.
Memory 56 is configured to store at least a portion of fall risk database 66. Fall risk database 66 includes a plurality of sets of data. Each set of data of the plurality of sets of data may, in some examples, correspond to an event detected in data collected by IMD 10. For example, at least one of the plurality of sets of data may correspond to a body position change or a body angle change detected in the accelerometer signal which is collected by IMD 10. Additionally, or alternatively, at least one of the plurality of sets of data may correspond to a cardiac event detected in one or more signals (e.g., EMG, impedance signals, optical signals, or any combination thereof) collected by IMD 10.
In some examples, each set of data of the plurality of sets of data includes respective portions of one or more signals, where the respective portions of the one or more signals correspond to a respective time window. For example, a first set of data may include a set of signals corresponding to a first time window and a second set of data may include a set of signals corresponding to a second time window, where the first time window is different than the second time window. The first set of data may include at least one of the same signals as the second set of data. As such, the first set of data and the second set of data may include at least one overlapping signal, although the first set of data corresponds to the first time window and the second set of data corresponds to the second time window.
Fall risk database 66 includes bins 68. In some examples, each of bins 68 may correspond to one or more classifications. A set of data may be sorted into bins 68 based on one or more classifications associated with the set of data. For example, bin 68A may be associated with a sit-to-stand classification and bin 68B may be associated with a lying-to-stand classification. Bins 68C-68N may each be associated with one or more of a plurality of classifications. When first set of data is associated with the sit-to-stand classification, memory 56 may store the first set of data in bin 68A. In some examples, processing circuitry (e.g., processing circuitry 14 of
Power source 64 is configured to deliver operating power to the components of IMD 10. Power source 64 may include a battery and a power generation circuit to produce the operating power. In some examples, the battery is rechargeable to allow extended operation. In some examples, recharging is accomplished through proximal inductive interaction between an external charger and an inductive charging coil within external device 12. Power source 64 may include any one or more of a plurality of different battery types, such as nickel cadmium batteries and lithium ion batteries. A non-rechargeable battery may be selected to last for several years, while a rechargeable battery may be inductively charged from an external device, e.g., on a daily or weekly basis.
Processing circuitry 80 may include fixed function circuitry and/or programmable processing circuitry. Processing circuitry 80 may include, for example, microprocessors, DSPs, ASICs, FPGAs, equivalent discrete or integrated logic circuitry, or a combination of any of the foregoing devices or circuitry. Accordingly, processing circuitry 80 may include any suitable structure, whether in hardware, software, firmware, or any combination thereof, to perform the functions ascribed herein to external device 12. In some examples, processing circuitry 80 may represent at least a portion of processing circuitry 14 of
Communication circuitry 82 may include any suitable hardware, firmware, software or any combination thereof for communicating with another device, such as IMD 10. Under the control of processing circuitry 80, communication circuitry 82 may receive downlink telemetry from, as well as send uplink telemetry to, IMD 10, or another device.
In some examples, memory 84 includes computer-readable instructions that, when executed by processing circuitry 80, cause external device 12 and processing circuitry 80 to perform various functions attributed to IMD 10 and processing circuitry 80 herein. Memory 84 may include one or both of a short-term memory or a long-term memory. The memory may include, for example, RAM, DRAM, SRAM, magnetic discs, optical discs, flash memories, or forms of EPROM or EEPROM. In some examples, the memory is used to store program instructions for execution by processing circuitry 80. Memory 84 may be used by software or applications running on external device 12 to temporarily store information during program execution. In some examples, fall risk database 66 may include one or more sets of data received from IMD 10 and sorted into bins 68.
Data exchanged between external device 12 and IMD 10 may include operational parameters. External device 12 may transmit data including computer readable instructions which, when implemented by IMD 10, may control IMD 10 to change one or more operational parameters and/or export collected data. For example, processing circuitry 80 may transmit an instruction to IMD 10 which requests IMD 10 to export collected data (e.g., data corresponding to one or both of an ECG signal and an accelerometer signal) to external device 12. In turn, external device 12 may receive the collected data from IMB 10 and store the collected data in memory 84. Additionally, or alternatively, processing circuitry 80 may export instructions to IMB 10 requesting IMD 10 to update electrode combinations for stimulation or sensing.
A user, such as a clinician or patient 4, may interact with external device 12 through user interface 86. User interface 86 includes a display (not shown), such as an LCD or LED display or other type of screen, with which processing circuitry 80 may present information related to IMD 10 (e.g., EGM signals obtained from at least one electrode or at least one electrode combination, impedance signals, motion signals, a fall risk score associated with patient 4 over time, or any combination thereof). In addition, user interface 86 may include an input mechanism to receive input from the user. The input mechanisms may include, for example, any one or more of buttons, a keypad (e.g., an alphanumeric keypad), a peripheral pointing device, a touch screen, or another input mechanism that allows the user to navigate through user interfaces presented by processing circuitry 80 of external device 12 and provide input. In other examples, user interface 86 also includes audio circuitry for providing audible notifications, instructions or other sounds to patient 4, receiving voice commands from patient 4, or both. Memory 84 may include instructions for operating user interface 86 and for managing power source 88.
Power source 88 is configured to deliver operating power to the components of external device 12. Power source 88 may include a battery and a power generation circuit to produce the operating power. In some examples, the battery is rechargeable to allow extended operation. Recharging may be accomplished by electrically coupling power source 88 to a cradle or plug that is connected to an alternating current (AC) outlet. In addition, recharging may be accomplished through proximal inductive interaction between an external charger and an inductive charging coil within external device 12. In other examples, traditional batteries (e.g., nickel cadmium or lithium ion batteries) may be used. In addition, external device 12 may be directly coupled to an alternating current outlet to operate.
Access point 90 may include a device that connects to network 92 via any of a variety of connections, such as telephone dial-up, digital subscriber line (DSL), or cable modem connections. In other examples, access point 90 may be coupled to network 92 through different forms of connections, including wired or wireless connections. In some examples, access point 90 may be a user device, such as a tablet or smartphone, that may be co-located with the patient. As discussed above, IMD 10 may be configured to transmit data, such as one or more sets of data to be analyzed in a fall risk analysis to external device 12. In addition, access point 90 may interrogate IMD 10, such as periodically or in response to a command from the patient or network 92, in order to retrieve parameter values determined by processing circuitry 50 of IMD 10, or other operational or patient data from IMD 10. Access point 90 may then communicate the retrieved data to server 94 via network 92.
In some cases, server 94 may be configured to provide a secure storage site for data that has been collected from IMD 10, and/or external device 12. In some cases, server 94 may assemble data in web pages or other documents for viewing by trained professionals, such as clinicians, via computing devices 100A-100N. One or more aspects of the illustrated system of
Server 94 may include processing circuitry 96. Processing circuitry 96 may include fixed function circuitry and/or programmable processing circuitry. Processing circuitry 96 may include any one or more of a microprocessor, a controller, a DSP, an ASIC, an FPGA, or equivalent discrete or analog logic circuitry. In some examples, processing circuitry 96 may include multiple components, such as any combination of one or more microprocessors, one or more controllers, one or more DSPs, one or more ASICs, or one or more FPGAs, as well as other discrete or integrated logic circuitry. The functions attributed to processing circuitry 96 herein may be embodied as software, firmware, hardware or any combination thereof. In some examples, processing circuitry 96 may perform one or more techniques described herein based on one or more sets of data received from IMD 10, as examples.
Server 94 may include memory 98. Memory 98 includes computer-readable instructions that, when executed by processing circuitry 96, cause IMD 10 and processing circuitry 96 to perform various functions attributed to IMD 10 and processing circuitry 96 herein. Memory 98 may include any volatile, non-volatile, magnetic, optical, or electrical media, such as RAM, ROM, NVRAM, EEPROM, flash memory, or any other digital media.
In some examples, one or more of computing devices 100A-100N (e.g., device 100A) may be a tablet or other smart device located with a clinician, by which the clinician may program, receive alerts from, and/or interrogate IMD 10. For example, the clinician may access data corresponding to any one or more of an EGM, an impedance signal, a tissue perfusion signal, an accelerometer signal, and other types of signals collected by IMD 10 through device 100A, such as when patient 4 is in between clinician visits, to check on a status of a medical condition such as a fall risk score. In some examples, the clinician may enter instructions for a medical intervention for patient 4 into an app in device 100A, such as based on the fall risk score determined by IMD 10, external device 12, processing circuitry 14, or any combination thereof, or based on other patient data known to the clinician. Device 100A then may transmit the instructions for medical intervention to another of computing devices 100A-100N (e.g., device 100B) located with patient 4 or a caregiver of patient 4. For example, such instructions for medical intervention may include an instruction to change a drug dosage, timing, or selection, to schedule a visit with the clinician, or to seek medical attention. In further examples, device 100B may generate an alert to patient 4 based on a status of a the fall risk score of patient 4 determined by IMD 10, external device 12, processing circuitry 14, or any combination thereof, which may enable patient 4 proactively to seek medical attention prior to receiving instructions for a medical intervention. In this manner, patient 4 may be empowered to take action, as needed, to address his or her medical status, which may help improve clinical outcomes for patient 4.
The change in the accelerometer signal plot 710 from accelerometer signal value A1 to accelerometer signal value A2 may represent a body position movement or a body angle movement of patient 4. In some examples, the accelerometer signal plot 710 may represent a plot of one axis of a three-axis accelerometer signal generated by motion sensor(s) 42. In some examples, the accelerometer signal plot 710 may indicates a magnitude of a vector of two or more axes of the accelerometer signal generated by motion sensor(s) 42. In any case, the accelerometer signal plot 710 may be substantially constant at accelerometer signal value A1 prior to time T1 and the accelerometer signal plot 710 may be substantially constant at accelerometer signal value A2 following time T2, where the value A2 is lower than the value A1. Processing circuitry 14 may determine that the change in the accelerometer signal from A1 to A2 represents a body position change and processing circuitry 14 may generate a set of data including one or more signals indicative of the physiological parameter represented by physiological parameter plot 720.
In some cases, the physiological parameter plot 720 increases from parameter value P1 to parameter value P2 in response to the accelerometer signal plot 710 changing from accelerometer signal value A1 to accelerometer signal value A2. Since the change from accelerometer signal value A1 to accelerometer signal value A2 may represent a body position change of patient 4, the physiological parameter change from parameter value P1 to parameter value P2 may occur responsive to the body position movement detected by processing circuitry 14 in the accelerometer signal shown in accelerometer signal plot 710. In some examples, processing circuitry 14 may analyze the physiological parameter change from parameter value P1 to parameter value P2 in order to determine whether the physiological parameter change meets an expected parameter change. For example, the “expected” parameter change may represent a minimum change in the parameter value responsive to the body position change indicated by the accelerometer signal plot 710 change from accelerometer signal value A1 to accelerometer signal value A2. When the difference between P1 and P2 is greater than the expected parameter change, processing circuitry 14 may determine that the parameter change from P1 to P2 meets the expected parameter change. When the difference between P1 and P2 is not greater than the expected parameter change, processing circuitry 14 may determine that the parameter change from P1 to P2 does not meet the expected parameter change.
In some examples, physiological parameter plot 720 may indicate a parameter such as blood pressure, heart rate, tissue perfusion, motion data, or gyroscopic data. When the body position change indicated by the change from accelerometer signal value A1 to accelerometer signal value A2 is represents a sit-to-stand or a lying-to-stand body movement, it may be expected that some physiological parameters such as blood pressure and heart rate will increase in order to compensate for the increased exertion associated with these body position movements. Additionally, processing circuitry 14 may determine that a time in which it takes for patient 4 to complete a body position movement (e.g., the time from T1 to T2) changes across a sequence of body position movements of the same type. Processing circuitry 14 may determine the fall risk score associated with patient 4 based on the change in the amount of time that it takes to complete a body position movement. For example, patient 4 may complete a sequence of sit-to-stand movements. If the amount of time that it takes patient 4 increases from a beginning of the sequence to the end of the sequence of sit-to-stand movements, processing circuitry 14 may determine that the patient 4 is at an increased risk of falling.
Processing circuitry 14 may identify one or more events based on data collected by IMD 10 and/or other medical devices or sensors. These events, when identified by processing circuitry 14, may represent reference points for analyzing data collected by the IMD 10 and/or other devices. For example, processing circuitry 14 may determine a time in which each identified event occurs and generate a set of data corresponding to each respective event. Additionally, processing circuitry 14 may classify each identified event according to one or more classifications and sort the set of data corresponding to each event into one or more bins associated with the one or more classifications assigned to the respective event. In turn, the processing circuitry 14 may analyze the sets of data in order to determine a fall risk score.
Processing circuitry 14 may identify, based on one or more signals collected by a medical device, an event (802). In some examples, the one or more signals include an accelerometer signal, an impedance signal (e.g., a subcutaneous impedance signal, an intrathoracic impedance signal, and/or an intracardiac impedance signal), and the event represents a body position movement event identified by processing circuitry 14 in the accelerometer signal. In some examples, the one or more signals include an EGM, an impedance signal (e.g., a subcutaneous impedance signal, an intrathoracic impedance signal, and/or an intracardiac impedance signal), a tissue oxygenation signal, or any combination thereof, and the event represents a cardiac event identified by processing circuitry 14 in the one or more signals. In some examples, the event represents another type of event identified in the accelerometer signal, the EGM, the impedance signal, the tissue oxygenation signal, another signal, or any combination thereof.
Processing circuitry 14 may identify a time or a period of time of the event (804). For example, when the event is a body position change, the processing circuitry 14 may determine, in the accelerometer signal, a time in which the body position change begins and a time in which the body position change ends. These times represent the period of time in which the body position change occurs. When the event is a cardiac event, the processing circuitry 14 may determine a time in which the cardiac event begins and a time in which the cardiac event ends. These times represent the period of time in which the cardiac event occurs.
Processing circuitry 14 may set a time window based on the time or period of time of the event (806). In some examples, the window of time may include at least a portion of time following the time or period of time in which the event occurs. In some examples, the entire window of time is after the time or period of time in which the event occurs. In some examples, at least a portion of the window of time occurs before the time or window of time in which the event occurs. Processing circuitry 14 may assign one or more classifications to the event (808). The one or more classifications may indicate aspects of the detected event. For example, the one or more classifications may include at least one type of body position movement, at least one type of body angle change, at least one time of day in which the event is detected, or at least one type of cardiac event.
Processing circuitry 14 may save, to a fall risk database in a memory, a set of data including at least some of the one or more signals so that the fall risk database may be analyzed in order to determine a fall risk score corresponding to patient 4 (810). For example, processing circuitry 14 may save a portion of one or more signals collected by IMD 10 or another medical device, where the portion of each respective signal corresponds to the window of time selected by processing circuitry 14. Processing circuitry 14 may save the set of data to one or more bins of the fall risk database based on the one or more classifications assigned to the event associated with the set of data. This allows processing circuitry 14 to analyze the one or more bins in order to determine a fall risk score associated with patient 4.
The techniques described in this disclosure may be implemented, at least in part, in hardware, software, firmware, or any combination thereof. For example, various aspects of the techniques may be implemented within one or more microprocessors, DSPs, ASICs, FPGAs, or any other equivalent integrated or discrete logic QRS circuitry, as well as any combinations of such components, embodied in external devices, such as physician or patient programmers, stimulators, or other devices. The terms “processor” and “processing circuitry” may generally refer to any of the foregoing logic circuitry, alone or in combination with other logic circuitry, or any other equivalent circuitry, and alone or in combination with other digital or analog circuitry.
For aspects implemented in software, at least some of the functionality ascribed to the systems and devices described in this disclosure may be embodied as instructions on a computer-readable storage medium such as RAM, DRAM, SRAM, magnetic discs, optical discs, flash memories, or forms of EPROM or EEPROM. The instructions may be executed to support one or more aspects of the functionality described in this disclosure.
In addition, in some aspects, the functionality described herein may be provided within dedicated hardware and/or software modules. Depiction of different features as modules or units is intended to highlight different functional aspects and does not necessarily imply that such modules or units must be realized by separate hardware or software components. Rather, functionality associated with one or more modules or units may be performed by separate hardware or software components or integrated within common or separate hardware or software components. Also, the techniques could be fully implemented in one or more circuits or logic elements. The techniques of this disclosure may be implemented in a wide variety of devices or apparatuses, including an IMD, an external programmer, a combination of an IMD and external programmer, an integrated circuit (IC) or a set of ICs, and/or discrete electrical circuitry, residing in an IMD and/or external programmer.
This application is a continuation of U.S. patent application Ser. No. 16/940,817, filed 28 Jul. 2020, the entire content of which is incorporated herein by reference.
| Number | Name | Date | Kind |
|---|---|---|---|
| 2009393 | Gioacchino | Jul 1935 | A |
| 4374382 | Markowitz | Feb 1983 | A |
| 4823797 | Heinze et al. | Apr 1989 | A |
| 4915686 | Frederick | Apr 1990 | A |
| 5107833 | Barsness | Apr 1992 | A |
| 5117824 | Keimel et al. | Jun 1992 | A |
| 5127404 | Wyborny et al. | Jul 1992 | A |
| 5168871 | Grevious | Dec 1992 | A |
| 5271395 | Wahlstrand et al. | Dec 1993 | A |
| 5292343 | Blanchette et al. | Mar 1994 | A |
| 5304119 | Balaban et al. | Apr 1994 | A |
| 5314450 | Thompson | May 1994 | A |
| 5324315 | Grevious | Jun 1994 | A |
| 5354319 | Wyborny et al. | Oct 1994 | A |
| 5383909 | Keimel | Jan 1995 | A |
| 5484403 | Yoakum et al. | Jan 1996 | A |
| 5545186 | Olson et al. | Aug 1996 | A |
| 5755736 | Gillberg et al. | May 1998 | A |
| 5772671 | Harmon | Jun 1998 | A |
| 5836975 | DeGroot | Nov 1998 | A |
| 5842999 | Pruitt et al. | Dec 1998 | A |
| 5876353 | Riff | Mar 1999 | A |
| 5913879 | Ferek-Petric et al. | Jun 1999 | A |
| 5954670 | Baker | Sep 1999 | A |
| 5957861 | Combs et al. | Sep 1999 | A |
| 5987352 | Klein et al. | Nov 1999 | A |
| 6045513 | Stone et al. | Apr 2000 | A |
| 6102874 | Stone et al. | Aug 2000 | A |
| 6104949 | Pitts Crick et al. | Aug 2000 | A |
| 6148233 | Owen et al. | Nov 2000 | A |
| 6154674 | Meier | Nov 2000 | A |
| 6221011 | Bardy | Apr 2001 | B1 |
| 6230059 | Duffin | May 2001 | B1 |
| 6263243 | Lang | Jul 2001 | B1 |
| 6277072 | Bardy | Aug 2001 | B1 |
| 6280380 | Bardy | Aug 2001 | B1 |
| 6280409 | Stone et al. | Aug 2001 | B1 |
| 6336903 | Bardy | Jan 2002 | B1 |
| 6405085 | Graupner et al. | Jun 2002 | B1 |
| 6412490 | Lee | Jul 2002 | B1 |
| 6449509 | Park et al. | Sep 2002 | B1 |
| 6459929 | Hopper et al. | Oct 2002 | B1 |
| 6463326 | Hartley et al. | Oct 2002 | B1 |
| 6473640 | Erlebacher | Oct 2002 | B1 |
| 6480733 | Turcott | Nov 2002 | B1 |
| 6512940 | Brabec et al. | Jan 2003 | B1 |
| 6512949 | Combs et al. | Jan 2003 | B1 |
| 6522915 | Ceballos et al. | Feb 2003 | B1 |
| 6572557 | Tchou et al. | Jun 2003 | B2 |
| 6595927 | Pitts-Crick et al. | Jul 2003 | B2 |
| 6620467 | Sudo et al. | Sep 2003 | B2 |
| 6622046 | Fraley et al. | Sep 2003 | B2 |
| 6625493 | Kroll et al. | Sep 2003 | B2 |
| 6647295 | Florio et al. | Nov 2003 | B2 |
| 6671549 | Van Dam et al. | Dec 2003 | B2 |
| 6719701 | Lade | Apr 2004 | B2 |
| 6788970 | Park et al. | Sep 2004 | B1 |
| 6821249 | Casscells, III et al. | Nov 2004 | B2 |
| 6866629 | Bardy | Mar 2005 | B2 |
| 6892094 | Ousdigian et al. | May 2005 | B2 |
| 6895275 | Markowitz et al. | May 2005 | B2 |
| 6907288 | Daum | Jun 2005 | B2 |
| 6931272 | Bumes | Aug 2005 | B2 |
| 6945934 | Bardy | Sep 2005 | B2 |
| 6960167 | Bardy | Nov 2005 | B2 |
| 7035684 | Lee | Apr 2006 | B2 |
| 7127290 | Girouard et al. | Oct 2006 | B2 |
| 7141026 | Aminian et al. | Nov 2006 | B2 |
| 7149584 | Koh et al. | Dec 2006 | B1 |
| 7177681 | Zhu | Feb 2007 | B2 |
| 7177684 | Kroll et al. | Feb 2007 | B1 |
| 7184821 | Belalcazar et al. | Feb 2007 | B2 |
| 7248916 | Bardy | Jul 2007 | B2 |
| 7272442 | Freeberg | Sep 2007 | B2 |
| 7308309 | Koh | Dec 2007 | B1 |
| 7310551 | Koh et al. | Dec 2007 | B1 |
| 7313434 | Belalcazar et al. | Dec 2007 | B2 |
| 7340296 | Stahmann et al. | Mar 2008 | B2 |
| 7387610 | Stahmann et al. | Jun 2008 | B2 |
| 7389143 | Hopper et al. | Jun 2008 | B2 |
| 7541934 | Fredriksson et al. | Jun 2009 | B2 |
| 7647106 | Virag et al. | Jan 2010 | B2 |
| 7937135 | Ghanem et al. | May 2011 | B2 |
| 7991471 | Ghanem et al. | Aug 2011 | B2 |
| 7996087 | Cowan et al. | Aug 2011 | B2 |
| 8206325 | Najafi et al. | Jun 2012 | B1 |
| 8255046 | Sarkar et al. | Aug 2012 | B2 |
| 8428720 | Corbucci et al. | Apr 2013 | B2 |
| 8491504 | Hirth | Jul 2013 | B2 |
| 8736453 | Wilson et al. | Jan 2014 | B2 |
| 8688201 | Corbucci et al. | Apr 2014 | B2 |
| 8744572 | Greenhut et al. | Jun 2014 | B1 |
| 8818505 | Bhunia et al. | Aug 2014 | B2 |
| 8845557 | Giuffrida et al. | Sep 2014 | B1 |
| 8888745 | Van Der Graaf et al. | Nov 2014 | B2 |
| 8990041 | Grabiner et al. | Mar 2015 | B2 |
| 9005141 | Najafi et al. | Apr 2015 | B1 |
| 9318012 | Johnson et al. | Apr 2016 | B2 |
| 9332924 | Thakur | May 2016 | B2 |
| 9403000 | Lyons et al. | Aug 2016 | B2 |
| 9452101 | Tomlinson et al. | Sep 2016 | B2 |
| 9795322 | Karunaratne et al. | Oct 2017 | B1 |
| 9848778 | Soykan | Dec 2017 | B2 |
| 9901290 | Najafi et al. | Feb 2018 | B2 |
| 9907959 | Skelton | Mar 2018 | B2 |
| 10052062 | De Sapio et al. | Aug 2018 | B2 |
| 10070824 | LeLorier | Sep 2018 | B2 |
| 10124172 | Lyons et al. | Nov 2018 | B2 |
| 10143395 | Chakravarthy | Dec 2018 | B2 |
| 10166001 | An | Jan 2019 | B2 |
| 10182729 | Zielinski et al. | Jan 2019 | B2 |
| 10226631 | Kane | Mar 2019 | B2 |
| 10264997 | Romrell et al. | Apr 2019 | B1 |
| 10335047 | Gunderson | Jul 2019 | B2 |
| 10506933 | Soykan | Dec 2019 | B2 |
| 10610132 | Gunderson et al. | Apr 2020 | B2 |
| 10765359 | Cho | Sep 2020 | B2 |
| 11375905 | Gunderson | Jul 2022 | B2 |
| 20010004234 | Petelenz et al. | Jun 2001 | A1 |
| 20010011153 | Bardy | Aug 2001 | A1 |
| 20010021801 | Bardy | Sep 2001 | A1 |
| 20010039504 | Linberg et al. | Nov 2001 | A1 |
| 20020004672 | Florio et al. | Jan 2002 | A1 |
| 20020026104 | Bardy | Feb 2002 | A1 |
| 20020115939 | Mulligan et al. | Aug 2002 | A1 |
| 20020132044 | Quarles | Sep 2002 | A1 |
| 20030028221 | Zhu et al. | Feb 2003 | A1 |
| 20030055461 | Girouard et al. | Mar 2003 | A1 |
| 20030125611 | Bardy | Jul 2003 | A1 |
| 20030149367 | Kroll et al. | Aug 2003 | A1 |
| 20030212445 | Weinberg | Nov 2003 | A1 |
| 20030220580 | Alt | Nov 2003 | A1 |
| 20040015197 | Gunderson | Jan 2004 | A1 |
| 20040082969 | Kerr | Apr 2004 | A1 |
| 20040102712 | Belalcazar et al. | May 2004 | A1 |
| 20040112151 | Maxwell et al. | Jun 2004 | A1 |
| 20040122484 | Hatlestad et al. | Jun 2004 | A1 |
| 20040172080 | Stadler et al. | Sep 2004 | A1 |
| 20040193154 | Leatherbury et al. | Sep 2004 | A1 |
| 20040249388 | Michelson | Dec 2004 | A1 |
| 20050090852 | Layne et al. | Apr 2005 | A1 |
| 20050096645 | Wellman et al. | May 2005 | A1 |
| 20050107768 | Ting | May 2005 | A1 |
| 20050115561 | Stahmann | Jun 2005 | A1 |
| 20050124908 | Belalcazar et al. | Jun 2005 | A1 |
| 20060020295 | Brockway et al. | Jan 2006 | A1 |
| 20060030892 | Kadhiresan et al. | Feb 2006 | A1 |
| 20060074434 | Wenstrom et al. | Apr 2006 | A1 |
| 20060097331 | Hattori et al. | May 2006 | A1 |
| 20060106415 | Gabbay | May 2006 | A1 |
| 20060174898 | Brown | Aug 2006 | A1 |
| 20060241701 | Markowitz et al. | Oct 2006 | A1 |
| 20060276848 | Min et al. | Dec 2006 | A1 |
| 20060293609 | Stahmann et al. | Dec 2006 | A1 |
| 20070010738 | Mark et al. | Jan 2007 | A1 |
| 20070021678 | Beck et al. | Jan 2007 | A1 |
| 20070067005 | Schatz et al. | Mar 2007 | A1 |
| 20070088394 | Jacobson | Apr 2007 | A1 |
| 20070088397 | Jacobson | Apr 2007 | A1 |
| 20070142732 | Brockway et al. | Jun 2007 | A1 |
| 20070156061 | Hess | Jul 2007 | A1 |
| 20070179515 | Matsutani et al. | Aug 2007 | A1 |
| 20070249992 | Bardy | Oct 2007 | A1 |
| 20080024293 | Stylos | Jan 2008 | A1 |
| 20080027349 | Stylos | Jan 2008 | A1 |
| 20080082001 | Hatlestad et al. | Apr 2008 | A1 |
| 20080154298 | Grayzel et al. | Jun 2008 | A1 |
| 20080161657 | Bullens et al. | Jul 2008 | A1 |
| 20080255626 | Fricke et al. | Oct 2008 | A1 |
| 20080281550 | Hogle et al. | Nov 2008 | A1 |
| 20080288200 | Noble | Nov 2008 | A1 |
| 20090030426 | Zinn et al. | Jan 2009 | A1 |
| 20090036917 | Anderson | Feb 2009 | A1 |
| 20090137946 | Nassiri et al. | May 2009 | A1 |
| 20090221937 | Smith et al. | Sep 2009 | A1 |
| 20090278934 | Ecker et al. | Nov 2009 | A1 |
| 20090312649 | Lian et al. | Dec 2009 | A1 |
| 20100010361 | Boute et al. | Jan 2010 | A1 |
| 20100011424 | Ushiku | Jan 2010 | A1 |
| 20100030090 | Zhang et al. | Feb 2010 | A1 |
| 20100030227 | Kast et al. | Feb 2010 | A1 |
| 20100030292 | Sarkar et al. | Feb 2010 | A1 |
| 20100030293 | Sarkar et al. | Feb 2010 | A1 |
| 20100087745 | Fischell et al. | Apr 2010 | A1 |
| 20100094252 | Wengreen et al. | Apr 2010 | A1 |
| 20100114241 | Donofrio et al. | May 2010 | A1 |
| 20100198097 | Sowelam | Aug 2010 | A1 |
| 20100198140 | Lawson | Aug 2010 | A1 |
| 20100210975 | Anthony, III et al. | Aug 2010 | A1 |
| 20100228308 | Cowan et al. | Sep 2010 | A1 |
| 20100331868 | Bardy | Dec 2010 | A1 |
| 20110040572 | Chmiel et al. | Feb 2011 | A1 |
| 20110071586 | Jacobson | Mar 2011 | A1 |
| 20110077865 | Chen et al. | Mar 2011 | A1 |
| 20110082350 | Koh | Apr 2011 | A1 |
| 20110106201 | Bhunia | May 2011 | A1 |
| 20110148400 | Doerr et al. | Jun 2011 | A1 |
| 20110172545 | Grudic et al. | Jul 2011 | A1 |
| 20110190835 | Brockway et al. | Aug 2011 | A1 |
| 20110288379 | Wu | Nov 2011 | A1 |
| 20120083705 | Yuen et al. | Apr 2012 | A1 |
| 20120109235 | Jacobson | May 2012 | A1 |
| 20120109236 | Jacobson et al. | May 2012 | A1 |
| 20120109237 | Xiao et al. | May 2012 | A1 |
| 20120157874 | Thakur | Jun 2012 | A1 |
| 20120259577 | Ganyi | Oct 2012 | A1 |
| 20120271177 | Emerson | Oct 2012 | A1 |
| 20120277546 | Soykan | Nov 2012 | A1 |
| 20120283705 | Lee et al. | Nov 2012 | A1 |
| 20130066169 | Rys et al. | Mar 2013 | A1 |
| 20130079861 | Reinert et al. | Mar 2013 | A1 |
| 20130085677 | Modi et al. | Apr 2013 | A1 |
| 20130123684 | Giuffrida et al. | May 2013 | A1 |
| 20130304414 | Levy et al. | Nov 2013 | A1 |
| 20140022079 | Wilson et al. | Jan 2014 | A1 |
| 20140024971 | Bunn et al. | Jan 2014 | A1 |
| 20140088442 | Soykan | Mar 2014 | A1 |
| 20140128778 | Chan et al. | May 2014 | A1 |
| 20140128963 | Quill et al. | May 2014 | A1 |
| 20140276130 | Mirelman et al. | Sep 2014 | A1 |
| 20140276928 | Vanderpool et al. | Sep 2014 | A1 |
| 20140330172 | Jovanov et al. | Nov 2014 | A1 |
| 20140358193 | Lyons et al. | Dec 2014 | A1 |
| 20140364769 | Chang et al. | Dec 2014 | A1 |
| 20150011840 | Gavriely | Jan 2015 | A1 |
| 20150185044 | Nie et al. | Jul 2015 | A1 |
| 20150257654 | Bennett-Guerrero | Sep 2015 | A1 |
| 20150286285 | Pantelopoulos et al. | Oct 2015 | A1 |
| 20150302720 | Zhang et al. | Oct 2015 | A1 |
| 20150313552 | Zhang et al. | Nov 2015 | A1 |
| 20150342540 | An et al. | Dec 2015 | A1 |
| 20160038093 | Sharma et al. | Feb 2016 | A1 |
| 20160045140 | Kitamura et al. | Feb 2016 | A1 |
| 20160058333 | Arnold et al. | Mar 2016 | A1 |
| 20160100776 | Najafi et al. | Apr 2016 | A1 |
| 20160155313 | Chang et al. | Jun 2016 | A1 |
| 20160175007 | Valbuena et al. | Jun 2016 | A1 |
| 20160192890 | Averina | Jul 2016 | A1 |
| 20160209232 | Yang et al. | Jul 2016 | A1 |
| 20160220153 | Annegarn et al. | Aug 2016 | A1 |
| 20160256694 | Shuros | Sep 2016 | A1 |
| 20170056667 | Kane | Mar 2017 | A1 |
| 20170067933 | Miller et al. | Mar 2017 | A1 |
| 20170112463 | An | Apr 2017 | A1 |
| 20170155877 | Johnson et al. | Jun 2017 | A1 |
| 20170188897 | Thein et al. | Jul 2017 | A1 |
| 20170213145 | Pathak et al. | Jul 2017 | A1 |
| 20170258346 | Vanderpool et al. | Sep 2017 | A1 |
| 20170344919 | Chang et al. | Nov 2017 | A1 |
| 20180035898 | Gunderson | Feb 2018 | A1 |
| 20180035920 | Gunderson et al. | Feb 2018 | A1 |
| 20180035924 | Gunderson et al. | Feb 2018 | A1 |
| 20180035956 | Gunderson et al. | Feb 2018 | A1 |
| 20180055386 | Zielinski et al. | Mar 2018 | A1 |
| 20180070889 | Lee et al. | Mar 2018 | A1 |
| 20180085021 | Chakravarthy | Mar 2018 | A1 |
| 20180103874 | Lee et al. | Apr 2018 | A1 |
| 20180132793 | Katra | May 2018 | A1 |
| 20180168460 | Morris | Jun 2018 | A1 |
| 20180168502 | Cho | Jun 2018 | A1 |
| 20180177436 | Chang et al. | Jun 2018 | A1 |
| 20180333083 | Orellano | Nov 2018 | A1 |
| 20190069794 | Bardy | Mar 2019 | A1 |
| 20190069851 | Sharma et al. | Mar 2019 | A1 |
| 20190103007 | Tan et al. | Apr 2019 | A1 |
| 20190150852 | Stone et al. | May 2019 | A1 |
| 20190167205 | An | Jun 2019 | A1 |
| 20190214146 | Dunias et al. | Jul 2019 | A1 |
| 20200046982 | Min | Feb 2020 | A1 |
| 20200174517 | Martinez et al. | Jun 2020 | A1 |
| 20200187864 | Sharma | Jun 2020 | A1 |
| 20200297230 | Thakur | Sep 2020 | A1 |
| 20210059568 | Gunderson | Mar 2021 | A1 |
| 20210093253 | Sarkar | Apr 2021 | A1 |
| 20210153751 | Gunderson | May 2021 | A1 |
| 20210345891 | Gill | Nov 2021 | A1 |
| 20220000421 | Ippolito | Jan 2022 | A1 |
| 20220031253 | Burnes et al. | Feb 2022 | A1 |
| 20220273236 | Zhou | Sep 2022 | A1 |
| Number | Date | Country |
|---|---|---|
| 1031481 | Mar 1989 | CN |
| 2621634 | Jun 2004 | CN |
| 2702718 | Jun 2005 | CN |
| 202342097 | Jul 2012 | CN |
| 469951 | Jan 1929 | DE |
| 4243641 | Sep 1994 | DE |
| 10148440 | Apr 2003 | DE |
| 1997427 | Mar 2008 | EP |
| 3034128 | Jun 2016 | EP |
| 2001502937 | Mar 2001 | JP |
| 2007516031 | Jun 2007 | JP |
| 2008528084 | Jul 2008 | JP |
| 2011092065 | May 2011 | JP |
| 9813091 | Apr 1998 | WO |
| 9833554 | Aug 1998 | WO |
| 200064336 | Nov 2000 | WO |
| 2001032260 | May 2001 | WO |
| 2002067449 | Aug 2002 | WO |
| 2003061759 | Jul 2003 | WO |
| 2004093985 | Nov 2004 | WO |
| 2005044116 | May 2005 | WO |
| 2005060306 | Jun 2005 | WO |
| 2006070124 | Jul 2006 | WO |
| 2006081432 | Aug 2006 | WO |
| 2007033194 | Mar 2007 | WO |
| 2007079354 | Jul 2007 | WO |
| 2008016551 | Feb 2008 | WO |
| 2010030942 | Mar 2010 | WO |
| 2012098356 | Jul 2012 | WO |
| 2014083538 | Jun 2014 | WO |
| 2017142488 | Aug 2017 | WO |
| 2020002566 | Jan 2020 | WO |
| Entry |
|---|
| “Guideline for the Prevention of Falls in Older Persons—American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopaedic Surgeons Panel on Falls Prevention,” Journal of the American Geriatrics Society, vol. 49, No. 5, May 2001, 9 pp. |
| Adamson et al., “Continuous Autonomic Assessment in Patients with Symptomatic Heart Failure . . . ” Circulation Journal of American Heart Association, vol. 110, No. 16, Jun. 30, 2004, pp. 2389-2394. |
| Alberts et al., “Using Accelerometer and Gyroscopic Measures to Quantify Postural Stability,” Journal of Athletic Training, vol. 50, No. 6, Jun. 2015, 11 pp. |
| Baer, et al. “Electronic Home Monitoring of Congestive Heart Failure Patients: Design and Feasibility”, Congestive Heart Failure, 5:105-113, May/Jun. 1999. |
| Barde et al., “What to use to express the variability of data: Standard deviation or standard error of mean?,” Perspectives in clinical Research, vol. 3, No. 3, Jul. 2012, 4 pp. |
| Berman et al. “Transthoracic Electrical Impedance as a Guide to Intravascular Overload”, Archives Surgery, vol. 102, Jan. 1971, pp. 61-64. |
| Chang et al., “A Wireless Accelerometer-Based Body Posture Stability Detection System and Its Application for Meditation Practitioners,” Sensors, ISSN: 1424-8220, Dec. 18, 2012, 13 pp. |
| Clark et al., “Improving the Validity of Activity of Daily Living Dependency Risk Assessment,” Journal of Applied Gerontology: The Official Journal of the Southern Gerontological Society, vol. 34, No. 3, Apr. 2015, 14 pp. |
| Devries et al., “Outcome instmments to measure frailty: A systematic review,” Ageing Research Reviews, vol. 10, accepted Sep. 2010, published Jan. 2011, 11 pp. |
| Ganea et al., “Multi-Parametric Evaluation of Sit-to-Stand and Stand-to-Sit Transitions in Elderly People,” Medical Engineering and Physics, vol. 33, No. 9, Apr. 23, 2011, pp. 1086-1093. |
| Giuberti et al., “Automatic UPDRS Evaluation in the Sit-to-Stand Task of Parkinsonians: Kinetic Analysis and Comparative Outlook on the Leg Agility Task”, IEEE Journal of Biomedical and Health Informatics, vol. 19, No. 3, May 2015, pp. 2168-2194. |
| Hubble et al., “Wearable Sensor Use for Assessing Standing Balance and Walking Stability in People with Parkinson's Disease: A Systematic Review,” Plos One, Apr. 20, 2015, 22 pp. |
| International Search Report and Written Opinion of International Application No. PCT/US2021/041742, dated Nov. 4, 2021, 13 pp. |
| Kearns et al., “Path Tortuosity in Everyday Movements of Elderly Persons Increases Fall Prediction Beyond Knowledge of Fall History, Medication USe and Standardized Gait and Balance Assessments,” Journal of the American Medical Directors Association, (JAMDA), vol. 13, No. 7, Sep. 2012, 7 pp. |
| Kearns et al., “Tortuosity in Movement Paths Is Related to Cognitive Impairment—Wireless Fractal Estimation in Assisted Living Facility Residents,” Methods of Information in Medicine, vol. 49, No. 6, Mar. 2010, 7 pp. |
| Kearns et al., “Wireless telesurveillance system for detecting dementia,” Gerontechnology, vol. 10, No. 2, Jan. 2011, 13 pp. |
| Lusignan, et al. “Compliance and Effectiveness of 1 Year's Home Telemonitoring,The Report of a Pilot Study . . . ” European Journal of Heart Failure, vol. 3, Apr. 2001, pp. 723-730. |
| McCrory et al., “Speed of Heart Rate Recovery in Response to Orthostatic Challenge—A Strong Risk Marker of Mortality,” Circulation Research, vol. 119, No. 5, Aug. 2016, 10 pp. |
| Millor et al., “Kinematic Parameters to Evaluate Functional Performance of Sit-to-Stand and Stand-to-Sit Transitions Using Motion Sensor Devices: a Systematic Review,” IEEE Transactions on Neural Systems and Rehabilitation Engineering, vol. 22, No. 5, Jun. 2014, 11 pp. |
| Odden et al., “Rethinking the Association of High Blood Pressure With Mortality in Elderly Adults: The Impact of Frailty,” Archives of Internal Medicine, vol. 172, No. 15, Aug. 2012, 7 pp. |
| Prosecution History from U.S. Appl. No. 16/940,817, dated Jun. 22, 2022 through Sep. 22, 2022, 31 pp. |
| Rigoberto et al., “Postural sway parameters using atriaxial accelerometer: Comparing elderly and young healthy adults,” Computer Methods in Biomechanics and Biomedical Engineering, Feb. 21, 2011, 12 pp. |
| Robertson et al., “Frailty and Cognitive impairment—A review of the evidence and causal mechanisms,” Ageing Research Reviews, vol. 12, No. 4, Sep. 2013, 12 pp. |
| Romero-Ortuno et al., “A Frailty Instrument for primary care: findings from the Survey of Health, Ageing and Retirement in Europe (SHARE),” BMC Geriatrics, vol. 10, No. 57, Aug. 2010, 12 pp. |
| Veltink, et al., “Detection of Static and Dynamic Activities Using Uniaxial Accelerometers”, IEEE Transactions on Rehabilitation Engineering, vol. 4, No. 4, Dec. 1996, 11 pp. |
| Wieling et al., “Testing for Autonomic Neuropathy: Heart Rate Changes After Orthostatic Manoeuvers and Static Muscle Contractions,” Clinical Science(London), vol. 64, No. 6, Jun. 1, 1983, pp. 581-586. |
| Wuerz et al., “Effects of Prehospital Medications on Mortality and Length of Stay in Congestive Heart Failure”, Annals of Emergency Medicine, vol. 21, No. 6, Jun. 1992, pp. 669-674. |
| Corrected Notice of Allowance from U.S. Appl. No. 16/940,817 dated Feb. 7, 2023, 2 pp. |
| Notice of Allowance from U.S. Appl. No. 16/940,817 dated Jan. 31, 2023, 10 pp. |
| Number | Date | Country | |
|---|---|---|---|
| 20230021724 A1 | Jan 2023 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 16940817 | Jul 2020 | US |
| Child | 17937127 | US |
